Food Order Intervention for Gestational Diabetes
Primary Purpose
Gestational Diabetes
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Food Order Therapy
Medical Nutrition Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Gestational Diabetes
Eligibility Criteria
Inclusion Criteria:
- Pregnant subjects ≥18 years old
- Newly diagnosed with GDM between 24-32 weeks of gestation with at least 2 days of self-monitored glucose logs or diagnosed via a 50g glucose challenge test (GCT) greater than 200mg/dL
Exclusion Criteria:
- Pre-existing diabetes prior to conception
- Patients whom do not plan on consuming at least 3 meals daily throughout gestation (e.g. during Ramadan)
- Requirement of special medical diet (e.g. from phenylketonuria, celiac disease, etc.)
- History of bariatric surgery
Sites / Locations
- Materal-Fetal Medicine of Weill Cornell Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Food Order Therapy + Medical Nutrition Therapy
Medical Nutrition Therapy Alone
Arm Description
Outcomes
Primary Outcome Measures
Feasibility of the Food Order Intervention
Measured via feasibility questionnaire.
Secondary Outcome Measures
Average 1-hour postprandial glucose
Averaged from self-monitored blood glucose logs.
Time to initiation of pharmacotherapy
Measured in weeks from enrollment in the study.
Proportion of patients requiring the addition of pharmacotherapy
Measured as a percentage of patients in each arm.
Birthweight
Measured in lbs.
Full Information
NCT ID
NCT03592784
First Posted
June 18, 2018
Last Updated
November 20, 2020
Sponsor
Weill Medical College of Cornell University
1. Study Identification
Unique Protocol Identification Number
NCT03592784
Brief Title
Food Order Intervention for Gestational Diabetes
Official Title
Carbohydrate-Last Food Order Intervention for Gestational Diabetes Mellitus
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Terminated
Why Stopped
Lack of enrollment during Covid pandemic, however sufficient data gathered for assessment of primary outcome
Study Start Date
June 18, 2018 (Actual)
Primary Completion Date
March 19, 2020 (Actual)
Study Completion Date
April 22, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a randomized controlled feasibility trial for women diagnosed with gestational diabetes mellitus (GDM). The current front-line treatment for GDM is medical nutrition therapy (MNT), i.e. personalized diets which may or may not include mild carbohydrate restriction. Use of carbohydrate restriction increases the risk of the mother developing ketosis, a harmful condition for both the mother and fetus. If MNT is not enough to stabilize blood sugar levels, then pharmaceuticals are prescribed. In patients with type-2 diabetes and prediabetes, the carbohydrate-last food order behavior has been shown to improve post-meal blood sugar control without the need of reduced carbohydrate intake. Given this data, the addition of this intervention to MNT in patients with GDM may be helpful in achieving controlled blood sugar levels without increasing the risk of ketosis. This study will include two randomized groups diagnosed with GDM. Patients in the control group will be prescribed standard MNT. Patients in the intervention group will have identical MNT but with additional food order instruction/therapy. All patients will be followed up with at 1-2 week intervals. At each follow-up the physician and dietician will analyze the patient's blood sugar measurements and, among additional factors, determine if pharmaceuticals should be added. Treatment will continue through delivery. The primary aim of this study is to assess the feasibility of the carbohydrate last food order in GDM and generate preliminary data on its effects on glucose control.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Food Order Therapy + Medical Nutrition Therapy
Arm Type
Experimental
Arm Title
Medical Nutrition Therapy Alone
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Food Order Therapy
Intervention Description
Instructing patient to, whenever possible, eat carbohydrates at the end of their meal.
Intervention Type
Behavioral
Intervention Name(s)
Medical Nutrition Therapy
Intervention Description
Key components of this therapy include counseling to incorporate portion control, increased intake of vegetables and low glycemic index carbohydrates, and mild carbohydrate restriction.
Primary Outcome Measure Information:
Title
Feasibility of the Food Order Intervention
Description
Measured via feasibility questionnaire.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Average 1-hour postprandial glucose
Description
Averaged from self-monitored blood glucose logs.
Time Frame
2, 4, 6, 8, 10, 12 weeks
Title
Time to initiation of pharmacotherapy
Description
Measured in weeks from enrollment in the study.
Time Frame
2, 4, 6, 8, 10, 12 weeks
Title
Proportion of patients requiring the addition of pharmacotherapy
Description
Measured as a percentage of patients in each arm.
Time Frame
Week 16 or End of study (at delivery)
Title
Birthweight
Description
Measured in lbs.
Time Frame
Week 16 or End of study (delivery)
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Pregnant subjects ≥18 years old
Newly diagnosed with GDM between 24-32 weeks of gestation with at least 2 days of self-monitored glucose logs or diagnosed via a 50g glucose challenge test (GCT) greater than 200mg/dL
Exclusion Criteria:
Pre-existing diabetes prior to conception
Patients whom do not plan on consuming at least 3 meals daily throughout gestation (e.g. during Ramadan)
Requirement of special medical diet (e.g. from phenylketonuria, celiac disease, etc.)
History of bariatric surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alpana P Shukla, MD
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Materal-Fetal Medicine of Weill Cornell Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Food Order Intervention for Gestational Diabetes
We'll reach out to this number within 24 hrs